找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Nanomedicine for Cancer Diagnosis and Therapy; Arshi Malik,Sarah Afaq,Mohammed Tarique Book 2021 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: ABS
31#
發(fā)表于 2025-3-27 00:54:38 | 只看該作者
Targeting Tumor Microenvironment Through Nanotheranostics,ancer tops the chart of global killers with an?exceptionally high mortality rate along with deaths due to cardiac attack and stroke. Several factors including complex tumor heterogeneity, ineffective delivery of chemotherapeutic drugs to the tumor sites along with high cytotoxicity and acquisition o
32#
發(fā)表于 2025-3-27 04:05:08 | 只看該作者
Therapeutic Applications of Noble Metal (Au, Ag, Pt)-Based Nanomedicines for Melanoma, the sun or due to genetic predisposition. Recent reports suggested that melanoma causes around 60,000 deaths worldwide. Conventional therapeutic approaches that are being applied for the treatment of melanoma include chemotherapy, surgery, immunotherapy, and radiation. However, the adverse side eff
33#
發(fā)表于 2025-3-27 08:01:36 | 只看該作者
Ethics in Nanomedicine,edical curriculum. As various approaches in Nanomedicine had progressed with enormous promise toward theranostic interventions, ethical queries also arise in conjunction. Nanomedicine is a unique niche in various facets, but it comes along with indications of dangers and uncertainties not confronted
34#
發(fā)表于 2025-3-27 12:09:15 | 只看該作者
35#
發(fā)表于 2025-3-27 14:39:04 | 只看該作者
f the new methodology, to yield the required development effort for the traditional case that can be compared to the measured effort with the proposed methodology. Compared with the traditional development of processes, a savings of 27% was achieved. There are currently process development methodolo
36#
發(fā)表于 2025-3-27 20:28:49 | 只看該作者
37#
發(fā)表于 2025-3-28 01:57:23 | 只看該作者
38#
發(fā)表于 2025-3-28 04:59:51 | 只看該作者
39#
發(fā)表于 2025-3-28 06:45:44 | 只看該作者
40#
發(fā)表于 2025-3-28 11:40:56 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 23:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
留坝县| 金坛市| 东海县| 武强县| 伊川县| 南召县| 清水河县| 通州区| 扶绥县| 黄浦区| 旌德县| 大理市| 巫山县| 揭东县| 河东区| 革吉县| 宜昌市| 福贡县| 丹凤县| 潞城市| 周宁县| 永州市| 巧家县| 雅江县| 绥中县| 内黄县| 中卫市| 璧山县| 呼玛县| 马山县| 云阳县| 宜城市| 汶川县| 高雄县| 柳林县| 江源县| 余干县| 永修县| 枣庄市| 永州市| 河北区|